Healthcare
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
10 in 11 APAC healthcare groups saw negative shareholder returns in 2016-2018: Bain
Rising costs, evolving regulations and reimbursement pressure eroded profits.
APAC's employer medical benefit costs may rise 8.7% in 2020
This growth will be led by Malaysia and Thailand.
Singapore lost $1.04b to migraines in 2018
Patients who experienced it for four to 14 days per month lost an average of $14,860.
Temasek advances in bid for stake in $2.5b Metro Pacific hospital unit
This could potentially be the biggest healthcare deal in the Philippines.
IHH Healthcare buys Prince Court Medical Centre for $240m
The deal would give IHH a larger share in the medical tourism market in Klang Valley.
IHH Healthcare profits up 28% to $57.42m in Q2
Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.
Chinese pharma sales to hit $268b by 2028: Fitch Solutions
The effects of regulatory change on the sales of patented medicine are expected to be mild.
Singapore telehealth firm inks deal with Vietnamese insurer
Bao Minh's customers can consult with a doctor on their phones.
Icon Group acquires Hong Kong oncology clinic SunTech Medical
It is keen to make inroads into the ageing city.
Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b
The pharma will assume ownership interests in five biopharma companies.
Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics
Subsidies will available in both polyclinics and CHAS clinics by end-2020.
Singapore medical device output grew 4.2% in June
The industry outperformed the output of the manufacturing sector, which fell 6.9%.
94% of Singapore firms attach international medical plans to healthcare programmes
This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.
VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2
China-based Weimai’s $155m funding round was one of the quarter’s notable deals.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy